| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998788 | Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha), Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha), |
|||
| A998789 | Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha), Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha), |
|||
| A998790 | Anti-IFNa1 Reference Antibody (rontalizumab), Anti-IFNa1 Reference Antibody (rontalizumab), |
|||
| A998791 | Anti-IFNa1 Reference Antibody (sifalimumab), Anti-IFNa1 Reference Antibody (sifalimumab), |
|||
| A998792 | Anti-IFNAR1 Reference Antibody (anifrolumab), Anti-IFNAR1 Reference Antibody (anifrolumab), |
|||
| A998793 | Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1), Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1), |
|||
| A998794 | Anti-IFNg Reference Antibody (AMG 811), Anti-IFNg Reference Antibody (AMG 811), |
|||
| A998795 | Anti-IFNg Reference Antibody (emapalumab), Anti-IFNg Reference Antibody (emapalumab), |
|||
| A998796 | Anti-IFNg Reference Antibody (fontolizumab), Anti-IFNg Reference Antibody (fontolizumab), |
|||
| A998797 | Anti-IgE (M1 prime) Reference Antibody (quilizumab), Anti-IgE (M1 prime) Reference Antibody (quilizumab), |
|||
| A998798 | Anti-IgE Reference Antibody (ligelizumab), Anti-IgE Reference Antibody (ligelizumab), |
|||
| A998799 | Anti-IgE Reference Antibody (omalizumab), Anti-IgE Reference Antibody (omalizumab), |
|||
| A998800 | Anti-IgE Reference Antibody (talizumab), Anti-IgE Reference Antibody (talizumab), |
|||
| A998801 | Anti-IGF1 Reference Antibody (xentuzumab), Anti-IGF1 Reference Antibody (xentuzumab), |
|||
| A998802 | Anti-IGF1R / CD221 Reference Antibody (cixutumumab), Anti-IGF1R / CD221 Reference Antibody (cixutumumab), |
|||
| A998803 | Anti-IGF1R / CD221 Reference Antibody (dalotuzumab), Anti-IGF1R / CD221 Reference Antibody (dalotuzumab), |
|||
| A998804 | Anti-IGF1R / CD221 Reference Antibody (figitumumab), Anti-IGF1R / CD221 Reference Antibody (figitumumab), |
|||
| A998805 | Anti-IGF1R / CD221 Reference Antibody (ganitumab), Anti-IGF1R / CD221 Reference Antibody (ganitumab), |
|||
| A998806 | Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R), Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R), |
|||
| A998807 | Anti-IGF1R / CD221 Reference Antibody (lonigutamAb), Anti-IGF1R / CD221 Reference Antibody (lonigutamAb), |